Ranbaxy Laboratories Ltd has announced the launch of BONISTA- Teriparatide injection for the treatment of Osteoporosis, in collaboration with the Hyderabad-based Virchow Biotech Pvt Ltd. Ranbaxy is the first company to launch this bio-generic product in the world. Commenting on the launch of the product, Mr Sanjeev I. Dani, Senior Vice-President and Regional Director (Asia & CIS), Ranbaxy, said, "With growing longevity, osteoporosis - a condition characterised by loss of bone mass, would gain increased attention. Ranbaxy has a number of new products in its pipeline including